Albemarle Corp (ALB US)
ALB US$90.56
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Share price activity
- Last (Price)
- 90.56
- Change
- ▼ -0.44 (-0.48)
- Bid / Ask
- 90.55 - 90.60
- Volume
- 719,639
- Turnover
- 15,521,212
- Open
- 92.13
- Day Range
- 90.44 - 93.21
- VWAP
- 91.50
- Prev Close
- 91.00
- Last Trade
- 02/11 7:00pm
Key information
- Sector
- Basic Materials
- Shares Issued
- 118,005,057
- NTA/Share
- 68.53
- Last Dividend
- 0.41
- Dividend Ex Date
- 11 SEP 2026
- Dividend Pay Date
- 1 OCT 2026
Current (USD) · FY2025
- Revenue
- 5,142.73
- EBITDA
- 314.26
- Profit
- -677.38
- Earnings Per Share (EPS)
- -5.76
- Dividend Per Share (DPS)
- 1.62
- Yield %
- 1.68
- Market Cap
- 10,686.54
- Price to Earnings Ratio (P/E)
- 335.41
Estimates (USD) · FY2027
- Revenue
- 6,523.58
- EBITDA
- 2,529.15
- Profit
- 1,532.14
- Earnings Per Share (EPS)
- 11.99
- Dividend Per Share (DPS)
- 1.65
Quantitative rating
Undervalued
- Economic Moat
- Narrow
- Financial Health
- Moderate
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Five-star price 118.55 Fair value 155.65 One-star price 204.36
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
- Fair Value
- 155.65
- Price / Fair Value
- 0.62
- Valuation
- Undervalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (118.55) to the one-star price (204.36).
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
| Price - closing or last bid | 96.96 |
| Price - 12 month high | 221.00 |
| Price - 12 month low | 88.08 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 2.31 |
| Market capitalization | 11,441.77 |
| 12 Month High price date | 7 MAY 2026 |
| 12 Month Low price date | 4 NOV 2025 |
| Volume - avg. trading volume for the last 3 months | 2.38 |
| Price - 1 Day % Change | -2.02% |
| Price - 13 week price percent change | -14.32% |
| Price - 26 week price percent change | -48.12% |
| Price - 5 Day % Change | 2.64% |
| Price - 52 week price percent change | 0.29% |
| Price - YTD price percent change | -31.72% |
| Price % Change Month To Date | -9.71% |
| EPS excluding extraordinary items - most recent fiscal year | -5.760 |
| EPS excluding extraordinary items - trailing 12 month | 0.270 |
| EPS Normalized - most recent fiscal year | -0.790 |
| Revenue/share - most recent fiscal year | 43.707 |
| Revenue/share - trailing 12 month | 46.544 |
| Book value per share - most recent fiscal year | 61.999 |
| Book value per share - most recent quarter | 68.140 |
| Book value (tangible) per share - most recent fiscal year | 68.534 |
| Book value (tangible) per share - most recent quarter | 74.996 |
| Cash per share - most recent fiscal year | 13.745 |
| Cash per share - most recent quarter | 13.829 |
| Cash Flow per share - most recent fiscal year | 4.996 |
| Cash Flow per share - trailing 12 month | 10.399 |
| Dividend per share - most recent fiscal year | 1.620 |
| Dividends per share - trailing 12 month | 1.625 |
| EBITD per share - trailing 12 month | 7.770 |
| EPS Basic excluding extraordinary items - most recent fiscal year | -5.760 |
| EPS Basic excluding extraordinary items - trailing 12 month | 0.470 |
| EPS including extraordinary items - most recent fiscal year | -5.760 |
| EPS including extraordinary items - trailing 12 month | 0.480 |
| Free Cash Flow per share - trailing 12 month | 6.791 |
| P/E excluding extraordinary items, most recent fiscal year | 359.11 |
| P/E Normalized, most recent fiscal year | 16.21 |
| Price to sales - most recent fiscal year | 2.08 |
| Price to Tangible Book - most fiscal year | 1.80 |
| Price to Free Cash Flow per Share - most recent fiscal year | 14.28 |
| Price to Cash Flow per share - trailing 12 month | 9.32 |
| Price to Book - most recent fiscal year | 1.42 |
| P/E excluding extraordinary items high, trailing 12 months | 530.56 |
| P/E excluding extraordinary items low, trailing 12 months | 342.74 |
| Net Debt, LFI | 245.10 |
| Net Debt, LFY | 1,678.65 |
| Dividend Yield - 5 Year Average | 1.00% |
| Dividend Yield - indicated annual dividend divided by closing price | 1.64% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 1.68% |
| Free Cash Flow - most recent fiscal year | -1.91 |
| LT debt/equity - most recent fiscal year | 32.95% |
| Payout ratio - most recent fiscal year | -28.13% |
| Total debt/total equity - most recent fiscal year | 33.70% |
| LT debt/equity - most recent quarter | 17.11% |
| Total debt/total equity - most recent quarter | 17.82% |
| Free Cash Flow - trailing 12 month | 861.95 |
| Payout ratio - trailing 12 month | 578.57% |
| Revenue - most recent fiscal year | 5,142.73 |
| Revenue - trailing 12 month | 5,907.90 |
| EBITD - most recent fiscal year | 314.26 |
| EBITD - trailing 12 month | 986.29 |
| Earnings before taxes - most recent fiscal year | -552.07 |
| Earnings before taxes - trailing 12 month | 171.71 |
| Net Income available to common - most recent fiscal year | -677.38 |
| Net Income available to common - trailing 12 months | 57.43 |
| Earnings before taxes Normalized - most recent fiscal year | -84.05 |
| Net Income Available to Common, Normalized - most recent fiscal year | -92.63 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 5.98 |
| Net Profit Margin % - 1st historical fiscal year | -9.05% |
| Net Profit Margin % - trailing 12 month | 4.71% |
| Operating margin - 1st historical fiscal year | 1.31% |
| Operating margin - trailing 12 month | 13.73% |
| Pretax margin - trailing 12 month | 2.91% |
| Pretax margin - 1st historical fiscal year | -10.74% |
| Operating Margin - 5 year average | 8.06% |
| Pretax Margin - 5 year average | -0.74% |
| Free Operating Cash Flow/Revenue, 5 Year Average | -3.16% |
| Free Operating Cash Flow/Revenue, TTM | 14.59% |
| Net Profit Margin - 5 year average | 6.33% |
| Return on average assets - most recent fiscal year | -2.76% |
| Return on average assets - trailing 12 month | 1.70% |
| Return on average equity - most recent fiscal year | -6.03% |
| Return on average equity - trailing 12 month | 3.60% |
| Return on average assets - 5 year average | 4.98% |
| Return on average equity - 5 year average | 9.61% |
| Net Income/employee - most recent fiscal year | -59,642.31 |
| Revenue/employee - most recent fiscal year | 659,324.74 |
| Revenue growth rate, 5 year | 10.45% |
| EPS growth rate, 5 year | — |
| Growth rate% - dividend, 3 year | 0.84% |
| Revenue/share (5 yr growth) | 8.33% |
| Growth rate% - Revenue, 3 year | -11.10% |
| Growth rate% - EPS, 3 year | — |
| Book value per share growth rate, 5 year | 9.19% |
| Capital Spending growth rate, 5 year | -7.06% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | -14.27% |
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Announcements
Announcements are available for ASX-listed companies only.
Opinion
Albermarle Corp (ALB US) US$109.47
ALB is the world’s largest listed lithium producer and is leading the way in 2026, breaking to new lows overnight, having more than halved from its May high. The recent news and underlying weakness in the stock are causing MN to reconsider our position.
Portfolio Amendments – International Equities Portfolio
We are making three changes to the International Equities Portfolio
Albemarle Corporation (NYSE: ALB) US$135.03
Albemarle has pulled back sharply from recent highs, bringing the world’s largest lithium producer back into more interesting territory. We previously owned ALB in the International Equities Portfolio, selling at ~$163. While that proved a little early as the stock continued higher, the subsequent retreat to around ~$130 has again put it on our Hitlist.
Albermarle Corp (ALB US) $US96.23
ALB was smacked ~9% overnight, the drop was primarily due to the company's announcement that it would sell a controlling stake in its Ketjen refining catalyst solutions business to KPS Capital Partners for $US660mn.
Albermarle Corp (ALB US) $US80.76
Overnight, US lithium giant ALB closed up +7% on the CATL news. This is not as exciting as yesterday's moves across Asia, suggesting today’s local session could be more muted.
Albermarle Corp (ALB US) $US50.76
The impact of Trump's tariffs was huge overnight, with ALB surging over +19%, albeit from a low base. In February, this $US7bn Li goliath company announced it could generate breakeven free cash flow in 2025 without lithium prices rising, positioning it well if/when Li prices can recover some of their deep losses.
Albermarle Corp (ALB US) $US79.25
ALB rose 3.5% overnight, finally offering some hope for the world's largest lithium (Li) producer, which has struggled over the last few years as the Li price plummeted.
Albemarle Corp (ALB US) $US97.49
US lithium goliath ALB has halved production and stopped expansion at its $2 billion lithium hydroxide plant in southwest Western Australia as Li prices tumbled.
Albemarle Corp (ALB US) $US103.28
Due to the extremely weak Li price, US lithium goliath ALB has halved production and stopped expansion at its $2 billion lithium hydroxide plant in southwest Western Australia, also writing down the asset’s value by about $1.5 billion.
Action
MM is selling ALB US in the International Equities Portfolio, taking a loss around $US109
MM is neutral towards Albermarle around US$109
MM is buying ALB US in the International Equities Portfolio, allocating 4% around $US136
MM is adding ALB US back onto the Hitlist ~$US130
MM is selling ALB US in the International Equities Portfolio, taking profit around $US163
MM is long and bullish towards ALB
MM is long and bullish on ALB
MM is cautiously bullish towards ALB
MM is long and bullish ALB
MM is long and bullish ALB
Business Summary
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Video
Relevant suggested news and content from the site
Video
Podcast
Video
Podcast
